Wellthy Therapeutics, now part of the TruDoc family since its acquisition on February 1, 2024, is an innovative healthcare entity focused on bridging health equity through digital care for chronic diseases. Founded in 2015 and headquartered in India, it addresses global healthcare challenges such as disparities in access, suboptimal patient outcomes, and socio-economic hurdles.
The company's value proposition lies in its patient-companion and concierge solutions, which leverage behavioral science to achieve scalable clinical and business results. Wellthy Therapeutics empowers its partners with the tools to create and manage advanced digital solutions through a singular, validated front-end and compliant back-end.
This acquisition by TruDoc marks a significant strategic expansion, allowing the conglomerate to enhance its presence across the GCC and India, bolstering its mission to drive digital healthcare innovation and equity on a global scale.